BAKHU HOLDINGS

Bakhu Holdings, Corp. holds a license to cell replication technology and related proprietary equipment, processes, and formulations to produce, manufacture, and sell cannabis-related byproducts—sometimes referred to in the industry as cannabinoids—exclusively in North and Central America and the Caribbean. Upon successful completion of an efficacy demonstration of the commercial viability of the technology, we intend to exploit this intellectual property through sublicenses with third parties that will incorporate the cell replication technology into production plants they fund and build to produce medical, food additive, and recreational cannabis-related products.